ISPOR

Founded in 1995 as an international multidisciplinary professional membership society, the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is the leading global professional society in pharmacoeconomics and outcomes research and advances the policy, science, and practice of pharmacoeconomics (health economics) and outcomes research (the scientific discipline that evaluates the effect of health care interventions on patient well-being including clinical, economic, and patient-centered outcomes).


ISPOR Announces Launch of New Website and IT Initiative

Society Rolls Out Phase I of Comprehensive Multiyear Plan Lawrenceville, NJ, USA—August 13, 2018—ISPOR, the professional society for health economics and outcomes research (HEOR), announced that it has launched phase I of its comprehensive, multiyear information technology (IT) initiative. This first phase of the IT initiative includes the launch of […]


ISPOR CEO Named a 2018 PharmaVOICE 100 Honoree

Nancy S. Berg Recognized as a Transformational Commander and Chief Lawrenceville, NJ, USA—August 6, 2018—ISPOR, the professional society for health economics and outcomes research, announced that CEO and Executive Director Nancy S. Berg has been named a 2018 PharmaVOICE 100 honoree by PharmaVOICE magazine. She has been recognized as a […]


Nurse Telephone Support and Home Telemonitoring Are Cost-Effective in Chronic Heart Failure Management

Value in Health study supports telehealth options in The Netherlands Lawrenceville, NJ, USA—July 23, 2018—Value in Health, the official journal of ISPOR (the professional society for health economics and outcomes research), announced today the publication of a study demonstrating that both nurse telephone support and home telemonitoring are cost-effective solutions […]


Challenging the Status Quo: Report Urges the Use of Local Context to Determine Cost-Effectiveness Thresholds in Low- and Middle-income Countries

Lawrenceville, NJ, USA—July 23, 2018—Value in Health, the official journal of ISPOR (the professional society for health economics and outcomes research), announced today the publication of a study challenging the use of generic global benchmarks in the establishment of cost-effectiveness analysis thresholds in low- and middle-income countries. The report, Use […]


Value in Health Impact Demonstrates 5th Consecutive Year of Double-Digit Growth

ISPOR Journal’s Impact Factor Increases to 5.494 Lawrenceville, NJ—June 28, 2018—ISPOR (the professional society for health economics and outcomes research) announced that the impact factor for Value in Health, the Society’s flagship journal, has increased to 5.494 based on new data released by Clarivate Analytics’ Journal Citation Reports. Value in […]


ISPOR Announces New Summit on Value Assessment

Summit Scheduled for October 19, 2018 in Washington, DC, USA Lawrenceville, NJ, USA—June 26, 2018—ISPOR, the professional society for health economics and outcomes research, announced a new ISPOR Summit “New Approaches to Value Assessment: Towards More Informed Pricing in Healthcare” scheduled for October 19, 2018 in Washington, DC, USA. As […]


Conference Theme and Plenary Speakers Announced for ISPOR Asia Pacific 2018

Region’s Leading Health Economics and Outcomes Research Conference to Focus on Informing Policy and Strengthening Healthcare Systems Lawrenceville, NJ, USA—June 25, 2018—ISPOR, the professional society for health economics and outcomes research, announced the theme and plenary sessions for its ISPOR Asia Pacific 2018 conference. The conference is scheduled for 8-11 […]


A Framework for the Use of Wearable Medical Devices in Regulatory Clinical Trials

Value in Health Reports on Recommendations From the ePRO Consortium  Lawrenceville, NJ, USA—June 19, 2018—Value in Health, the official journal of ISPOR (the professional society for health economics and outcomes research), announced today the publication of new guidance regarding the selection and evaluation of wearable devices for use in regulatory […]


Novel Approach to Assessing US Outpatient Drug Costs for Use in Cost-Effectiveness Analyses

New Strategy Is Transparent, Consistent, and Applicable to All US-Based Cost-Effectiveness Analyses  Lawrenceville, NJ, USA—June 19, 2018—Value in Health, the official journal of ISPOR (the professional society for health economics and outcomes research), announced today the publication of a study introducing a novel strategy for obtaining reasonable drug cost estimates for […]


ISPOR Announces 2018-2019 Board of Directors

Lawrenceville, NJ, USA—June 5, 2018—ISPOR, the professional society for health economics and outcomes research, announced the election of the Society’s 2018-2019 Board of Directors. ISPOR’s global membership elects its board with the 2018-2019 Board of Directors assuming office on July 1, 2018. Federico Augustovski, MD, MSc, PhD will assume the […]


ISPOR 2018 Drew Nearly 4000 Stakeholders in Health Economics and Outcomes Research

Conference Focused on Real-World Evidence, Digital Health, and the New Healthcare Landscape Lawrenceville, NJ, USA—June 4, 2018—ISPOR, the professional society for health economics and outcomes research, recently concluded its ISPOR 2018 conference in Baltimore, MD, USA. The conference drew 3741 healthcare stakeholders representing 70 countries from all sectors of healthcare, […]


Strengths and Limitations of Patient Preferences to Inform Regulatory Decisions

Baltimore, MD, USA—May 23, 2018—ISPOR, the professional society for health economics and outcomes research, held its third plenary session, “Examining the Role of Patient Preferences to Inform Regulatory Decisions,” this morning at ISPOR 2018 in Baltimore, MD, USA. Healthcare research is increasingly seeking to better understand patients’ views related to […]


ISPOR Panel Discusses Recommendations and Rationale of “Making Medicines Affordable: A National Imperative”

Session Explores Strategies to Tackle Rising Costs of Prescription Drugs in the United States Without Discouraging Development Baltimore, MD, USA—May 22, 2018—ISPOR, the professional society for health economics and outcomes research, held a session, “‘Making Medicines Affordable: A National Imperative’—Reflections on the National Academies Report” [IP11], this afternoon at ISPOR […]


ISPOR Presents 2018 Awards for Outstanding Achievement in Health Economics and Outcomes Research

Honorees Recognized for Excellence in HEOR Baltimore, MD, USA—May 22, 2018—ISPOR, the professional society for health economics and outcomes research, recognized honorees of the ISPOR Awards Program at its ISPOR 2018 conference in Baltimore, MD, USA this week. The ISPOR Awards Program is designed to foster and acknowledge excellence and […]


Digital Health—Help or Hype?

Baltimore, MD, USA—May 22, 2018—ISPOR, the professional society for health economics and outcomes research, held its second plenary session, “Digital Health—Help or Hype?,” this morning at ISPOR 2018 in Baltimore, MD, USA. As digital technologies such as smart phones, social media, and wearables have increasingly become available, the potential opportunities […]